Class II

Drug Recall: Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01

ProRx LLC · August 22, 2024

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

37 vials

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0651-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

ProRx LLC Drug Recall: Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01 | SafeCheck